Dr. Abou-Alfa Discusses Ongoing Studies of Immunotherapy in HCC – OncLive
OncLive |
Dr. Abou-Alfa Discusses Ongoing Studies of Immunotherapy in HCC
OncLive Ghassan K. Abou-Alfa, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses ongoing studies investigating immunotherapy in hepatocellular carcinoma (HCC). The field of immunotherapy in HCC is moving extremely fast, Abou-Alfa … |
